Skip to main content
. 2021 Mar 1;2(4):100157. doi: 10.1016/j.jtocrr.2021.100157

Figure 5.

Figure 5

Impact of brain metastases on outcome. (A) Median survival after ALK TKI initiation. (B) Median progression-free survival. CI, confidence interval; TKI, tyrosine kinase inhibitor.